Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089825 · ClinicalTrials.gov registry record · NA
Telehealth & HPV Self-Collection
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT05089825 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 131 participants.
The verdict
NCT05089825, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
This study aims to compare the efficacy and participant experience of telehealth-based, self-collected cervical cancer screening to mail-based, self-collected cervical cancer screening across the adult female screening lifespan. This will be done by evaluating sufficient Human papillomavirus (HPV) sample collection and determining preference for self-collection verses provider collection, comparing role of telehealth in pre- and post- menopausal women's comfort with self-collection, comparing self-collection completion rates for women with and without telehealth visits.
Interventions
- OTHER Receive routine instructions
- OTHER Telehealth-based instructional visit and receive routine instructions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2023-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089825
The ClinicalTrials.gov registry entry for NCT05089825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Receive routine instructions is the first listed.
NCT05089825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05089825 about?
NCT05089825 is a clinical study titled "Telehealth & HPV Self-Collection". This study aims to compare the efficacy and participant experience of telehealth-based, self-collected cervical cancer screening to mail-based, self-collected cervical cancer screening across the adult female screening lifespan. This will be done by evaluating sufficient Human papillomavirus (HPV) s...
What is the current status of trial NCT05089825?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2022-01-19. Estimated completion is 2023-01-19.
What interventions are being tested in trial NCT05089825?
The interventions under investigation include: Receive routine instructions (OTHER), Telehealth-based instructional visit and receive routine instructions (OTHER).
Who is sponsoring clinical trial NCT05089825?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.